BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30578255)

  • 1. Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.
    Joly F; Cohen C; Javaugue V; Bender S; Belmouaz M; Arnulf B; Knebelmann B; Nouvier M; Audard V; Provot F; Gnemmi V; Nochy D; Goujon JM; Jaccard A; Touchard G; Fermand JP; Sirac C; Bridoux F
    Blood; 2019 Feb; 133(6):576-587. PubMed ID: 30578255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
    Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
    Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease.
    Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K
    Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal monoclonal immunoglobulin deposition disease: the disease spectrum.
    Lin J; Markowitz GS; Valeri AM; Kambham N; Sherman WH; Appel GB; D'Agati VD
    J Am Soc Nephrol; 2001 Jul; 12(7):1482-1492. PubMed ID: 11423577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal gammopathy presenting as recurrent nephrotic syndrome: therapeutic implications.
    Krishnan SG; Valderrama E; Wagner JD; Mattana J; Shah HH; Appel G; Singhal PC
    Am J Med Sci; 2007 May; 333(5):313-6. PubMed ID: 17505177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Randall-type monoclonal immunoglobulin deposition disease: From diagnosis to treatment].
    Cohen C; Javaugue V; Joly F; Arnulf B; Fermand JP; Jaccard A; Sirac C; Knebelmann B; Bridoux F; Touchard G
    Nephrol Ther; 2016 Jun; 12(3):131-9. PubMed ID: 27117766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease.
    Cohen C; Royer B; Javaugue V; Szalat R; El Karoui K; Caulier A; Knebelmann B; Jaccard A; Chevret S; Touchard G; Fermand JP; Arnulf B; Bridoux F
    Kidney Int; 2015 Nov; 88(5):1135-43. PubMed ID: 26176826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
    Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
    Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
    Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens.
    Ziogas DC; Kastritis E; Terpos E; Roussou M; Migkou M; Gavriatopoulou M; Spanomichou D; Eleutherakis-Papaiakovou E; Fotiou D; Panagiotidis I; Kafantari E; Psimenou E; Boletis I; Vlahakos DV; Gakiopoulou H; Matsouka C; Dimopoulos MA
    Leuk Lymphoma; 2017 Aug; 58(8):1832-1839. PubMed ID: 27967286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
    Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
    Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal immunoglobulin light and heavy chain deposition diseases: molecular models of common renal diseases.
    Ronco P; Plaisier E; Aucouturier P
    Contrib Nephrol; 2011; 169():221-231. PubMed ID: 21252522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
    Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F
    Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases.
    Buxbaum J; Gallo G
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1235-48. PubMed ID: 10626147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias.
    Gallo G; Picken M; Buxbaum J; Frangione B
    Semin Hematol; 1989 Jul; 26(3):234-45. PubMed ID: 2506646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light chain deposition disease affecting the gastrointestinal tract in the setting of post-living donor kidney transplantation.
    Jimenez-Zepeda VH; Vajpeyi R; John R; Trudel S
    Int J Hematol; 2012 Jul; 96(1):125-31. PubMed ID: 22573235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
    Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
    Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognosis of monoclonal immunoglobulin-associated glomerular diseases with non-organized deposits: A report of 38 cases from a Japanese single center.
    Nara M; Komatsuda A; Sawamura M; Abe F; Kaga H; Saito A; Saito M; Imaizumi C; Nanjo H; Wakui H; Takahashi N
    Clin Nephrol; 2022 Sep; 98(3):135-145. PubMed ID: 35818814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
    Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
    Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.